Showing results (91-100 of 589) with videos related to

Sort By:
Pageof 59
Journal for Immunotherapy of Cancer|August 7, 2019
A case of checkpoint inhibitor-induced celiac diseaseDana Alsaadi, Neil J Shah, Aline Charabaty, et al.
Angewandte Chemie (International Ed. in English)|December 22, 2018
High Throughput Strategies for the Discovery and Optimization of Catalytic ReactionsEric S Isbrandt, Ryan J Sullivan, Stephen G Newman
Immunological Reviews|August 14, 2023
Effects of immune-related adverse events (irAEs) and their treatment on antitumor immune responsesSteven M Blum, Sherin J Rouhani, Ryan J Sullivan
Methods in Molecular Biology (Clifton, N.J.)|November 22, 2013
Assaying for BRAF V600E in tissue and blood in melanomaDavid J Panka, James W Mier, Ryan J Sullivan
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 30, 2016
Molecular Pathways: Receptor Ectodomain Shedding in Treatment, Resistance, and Monitoring of CancerMiles A Miller, Ryan J Sullivan, Douglas A Lauffenburger
Cancer|February 28, 2017
Immune checkpoint inhibitors in challenging populationsDouglas B Johnson, Ryan J Sullivan, Alexander M Menzies
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 4, 2013
The intersection of immune-directed and molecularly targeted therapy in advanced melanoma: where we have been, are, and will beRyan J Sullivan, Patricia M Lorusso, Keith T Flaherty
Cancer Research|February 3, 2006
The Raf inhibitor BAY 43-9006 (Sorafenib) induces caspase-independent apoptosis in melanoma cellsDavid J Panka, Wei Wang, Michael B Atkins, et al.
Pageof 59